Our study revealed that circCCDC134 was involved in regulating NSCLC progression through the miR-625-5p/NFAT5 pathway, confirming that circCCDC134 might function as the diagnostic and therapeutic target for NSCLC.
A novel molecular mechanism mediated by circCCDC134 regulates non-small cell lung cancer progression.